Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F4C9T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,900
Award facts
- Contract value 100% obligated
- $18,899.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Xeljanz XR 11 mg tablets (30-count units) with a ceiling value of $18,899.73. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by December 8, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026 that enables the contractor to supply a broad range of medications and medical commodities to support military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with the DLA Medical Supply Chain, covering diverse therapeutic domains including neurological treatments, pain management, diabetes medications, and specialized medical supplies. Through its prime indefinite delivery contract and subsequent delivery orders, AmerisourceBergen supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the DLA Troop Support planning to expand pharmaceutical procurement through its Pharmaceutical Prime Vendor Global Program Generation V with multiple regional awards.
Quick answers
Who was awarded contract SPE2DR26F4C9T?
SPE2DR26F4C9T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26F4C9T worth?
The government has obligated $18,900 on SPE2DR26F4C9T.
Is contract SPE2DR26F4C9T an order under another contract?
Yes. SPE2DR26F4C9T is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4C9T competed?
The extent of competition for SPE2DR26F4C9T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award